ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0495

Seasonal Variation in the Incidence of GCA in the UK and Ireland

Leah Rooney1, Lorraine O'Neill1 and Eamonn Molloy2, 1St Vincent's University Hospital, Dublin, Ireland, 2St Vincent's Healthcare Group, Dublin, Ireland

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Giant Cell Arteritis (GCA) is the most common primary systemic vasculitis in adults, occurring in individuals over age 50, most frequently in women (3:1, F:M) and in those of Northern European descent. While genetic factors contribute to the increased incidence in Northern Europe, environmental triggers are likely to also play a role. Seasonal and cyclical fluctuations in incidence have been demonstrated in some cohorts. Environmental triggers may play a role in inducing vascular inflammation and also may contribute to the differing patterns of disease seen in GCA.

The objective of our study was to investigate the seasonal variation in the incidence of GCA in one geographical region – the United Kingdon and Ireland. To do this, we used three GCA datasets: from the TABUL study, DCVAS and from St Vincent’s University Hospital (SVUH). The TABUL study (Temporal Artery Biopsy vs Ultrasound in Diagnosis of GCA), a prospective multicentre study, recruited newly suspected GCA patients from sites in Europe. The DCVAS (Diagnostic and Classification Criteria in Vasculitis), a multinational observational study aiming to develop diagnostic criteria in vasculitis, recruited patients from 136 sites in 32 countries, 1220 patients had a diagnosis of GCA. The St Vincent’s University Hospital GCA registry has prospectively recruited patients with GCA from 3 hospital sites in Dublin.

Methods: Using data from the three GCA datasets, we looked at month and year of onset of GCA symptoms or diagnosis date, dependant on available data. For each of the datasets, cases from the UK and Ireland were included from years where complete data was available (2011-2016 for DCVAS, 2011-2013 for TABUL and 2012-2016 for SVUH). Patients who were included in more than one of these datasets were identified and duplicates were removed.

Results: We included a total of 719 GCA patients, from the UK and Ireland, in this study: 202 from the SVUH registry (2012-2016), 201 from the TABUL dataset (2011-2013, excluding SVUH duplicates) and 316 from DC-VAS dataset (2011-2016, excluding duplicates from the SVUH and TABUL databases).

Overall, we found a higher incidence of GCA during the spring and early summer compared to the autumn and winter.

Similarly, when analysed individually, each year had a peak in GCA incidence during the spring/early summer with most years having a 2nd peak in the Autumn or Winter.

Conclusion: Analysis of these GCA datasets suggests there is a peak in incidence of GCA in the spring/early summer. This further supports the role of environmental triggers in the pathogenesis of GCA.

Acknowledgements:
TABUL and DCVAS investigators.

Supporting image 1

Total GCA incidence by month

Supporting image 2

GCA incidence by season

Supporting image 3

GCA incidence by month, 2011_2016


Disclosures: L. Rooney, None; L. O'Neill, None; E. Molloy, None.

To cite this abstract in AMA style:

Rooney L, O'Neill L, Molloy E. Seasonal Variation in the Incidence of GCA in the UK and Ireland [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/seasonal-variation-in-the-incidence-of-gca-in-the-uk-and-ireland/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-variation-in-the-incidence-of-gca-in-the-uk-and-ireland/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology